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Abstract
Background: Ischemia preconditioning (IPC) has been proved as a powerful method of protecting tissues against
ischemia reperfusion insults. We aimed to elucidate the mechanism of IPC in ischemia reperfused tissues.
Methods: GSE21164 containing 16 muscle biopsies taken from the operative knee of four IPC-treated patients and
four control at the onset of surgery (T = 0) and 1 h into surgery (T = 1) undergoing primary total knee arthroplasty
was downloaded from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs)
between IPC group and control were screened with Limma package in R language. KEGG pathway enrichment
analysis was performed by the DAVID online tool. Meanwhile, potential regulatory microRNAs (miRNAs) for
downregulated DEGs and targets of transcription factors for upregulated DEGs were screened out. Based on the
above DEGs, protein-protein interaction (PPI) networks were constructed by the STRING software.
Results: Significantly upregulated DEGs at T1 were mainly enriched in asthma and p53 signaling pathway.
Meanwhile, significantly enriched transcriptional factor NOTCH1 at T1 and GABP at T0 were obtained. Moreover,
miRNA analysis showed that targets of miR141/200a were enriched in downregulated DEGs both at T0 and T1.
Mostly, RPA1 and JAK2 in PPI network at T1 were with higher degree.
Conclusions: In our study, obtained DEGs, regulatory transcriptional factors, and miRNA might play a vital role
in the protection of ischemia reperfusion injury. This finding will provide a deeper understanding to the
mechanism of IPC.
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Background
Many surgical procedures involve prolonged ischemia of
organs or tissues which can lead to sever postoperative
complications, including dysfunction and necrosis [1]. In
order to prevent ischemia-reperfusion injury, Murry
et al. first documented the protective effect of ischemia
preconditioning (IPC) in 1986 [2]. IPC has been proved
as an extremely powerful method of protecting tissues
against subsequent sustained ischemia insults [3] when
it is firstly subjected to short bursts of ischemia and
reperfusion. This method is universally applicable in
modulating ischemia-reperfusion injury to tissues in-
cluding the myocardium [4], brain [5], liver [6], lung [7],
kidney [8], intestine [9], and skeletal muscle [10]. IPC is
thought to provide protection by inducing tissues’ toler-
ance to ischemia, therefore reducing oxidative stress
[11], inflammation, and apoptosis [12].
The complex mechanism of protection through IPC has
partially been demonstrated. Studies have shown that re-
lease of signaling molecules such as adenosine, bradykinin,
reactive oxygen species (ROS), catecholamines, and opi-
oids can trigger protective response through various cell
surface G-protein coupled receptors [13-16]. The released
agonists then might activate protecting signaling pathway.
Kinases such as protein kinase C [17], PI-3 K [18], tyrosine
kinase [19], and MAPK kinase [20] play a vital role in the
signaling pathway. IPC exerts a protective effect through
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upregulating heat shock proteins, reducing oxidative stress
and inhibition of apoptosis in tissue injury [21].
In recent studies, microarray analysis for IPC effect
was utilized to assess the gene expression after ischemia
reperfusion. Murphy and colleagues screened differen-
tially expressed genes (DEGs) > 1.5-fold and performed
gene ontology analysis from GSE21164 [22]. Chunxiao
Li also searched related motif and phosphorylation sites
for significant DEGs [23] using same gene data. With
the same limitation, they did not perform deep analysis
for GSE21164. As a result, the mechanism of IPC pro-
tection in humans has not fully been elucidated.
For better understanding the effect of IPC, we carried
out deep analysis in additional to DEGs screening and
pathway analysis to explore molecular mechanism of
protective effect of IPC. First of all, we predicted tran-
scriptional factor in upregulated DEGs and evaluated
microRNA (miRNA) targets in downregulated DEGs in
our study. In addition, we constructed protein-protein
interaction (PPI) network based on up- and downregu-
lated DEGs at the onset of surgery (T = 0) and 1 h into
surgery (T = 1).
Materials and methods
Microarray data
The gene expression profile of GSE21164 based on the
platform GPL570 Affymetrix Human Genome U133 Plus
2.0 Array was obtained from National Center of Biotech-
nology Information (NCBI) Gene Expression Omnibus
(GEO) database (http://www.ncbi.nlm.nih.gov/geo/). A
total of eight patients undergoing total knee arthroplasty
were randomized to IPC treatment group (n = 4) and
control group (n = 4). Patients in the IPC group received
IPC stimulus which consisted of three 5-min periods of
tourniquet insufflation on the lower operative limb and
interrupted by 5-min periods of reperfusion prior to
total knee arthroplasty. Comparisons for gene expression
of muscle biopsies taken from the operative leg between
the IPC group and the control both at the onset of sur-
gery (T = 0) and 1 h into surgery (T = 1) were performed
for future analysis.
Date preprocessing and DEGs screening
For each sample of GSE21164, the original expression
datasets were converted into recognizable format and
standardized using robust multi-array analysis (RMA)
method [24]. Then, the RMA signal values were sub-
jected to log2 transformation. To identify DEGs between
the IPC group and the control, the empirical Bayes test
(implemented in Linear Models for Microarray Data
(Limma) package [25]) was applied in our analysis. P values
were determined by Student’s t test. Log 2 |fold change
(FC)| > 0.26 (|FC| > 1.2) and P < 0.05 were chosen as the
cutoff criteria for screening DEGs.
Pathway enrichment analysis and prediction of
transcriptional factors and regulatory miRNAs
Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathway annotation for DEGs was carried out using
Database for Annotation, Visualization and Integrated
Discovery (DAVID) [26] online tool. P < 0.05 was se-
lected as the cutoff criterion. For prediction of the key
transcriptional factors that regulated the expression
of the upregulated DEGs, ChAE (ChIP Enrichment
Analysis) [27] tool was utilized under the criteria of
P < 0.005. Furthermore, Fisher’s exact test was applied
to identify the significant miRNAs which targeted
downregulated DEGs in TargetScan [28] database with
P < 0.005.
Construction of PPI network
Building interaction network is beneficial for under-
standing of protein functions because most proteins play
an important role in biological activity in the form of
complexes not work alone. STRING software [29] was
utilized to establish the interaction networks for signifi-
cant up- and downregulated DEGs. Then, Cytoscape
[30] was employed to explore and plot PPI network.
Node degree is the number of interactions for a node, in
other words, the number of other nodes which con-
nected with directly. We calculated the node degree with
significance in PPI network.
Results
DEGs identification and KEGG pathway enrichment
analysis
Based on the cutoff criteria of |FC| > 1.2 and P < 0.05, we
screened 372 up- and 227 downregulated DEGs from
IPC group at the onset of surgery (T = 0). Besides, at 1 h
into surgery (T = 1), 419 up- and 383 downregulated
DEGs were obtained.
The KEGG pathway enrichment analysis was per-
formed for both up- and downregulated DEGs at T0 and
T1. Upregulated DEGs at T0 were mainly enriched in
aminoacyl-tRNA biosynthesis. At T1, upregulated genes
were mostly enriched in Soluble NSF Attachment Pro-
tein receptor (SNARE) interactions in vesicular trans-
port, asthma, graft-versus-host disease, melanogenesis,
and p53 signaling pathway, while downregulated genes
at T1 were significantly enriched in chemokine signaling
pathway (Table 1).
Significant transcriptional factors for upregulated DEGs
Considering that most changes in gene expression are
controlled by upstream regulatory transcriptional fac-
tors, we searched on ChEA for transcriptional factors
that could regulate the 791 upregulated genes identified
both at T0 and T1. A total of 12 transcriptional factors
at T0 and 13 at T1 with statistical significance were
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found probably to modulate upregulated DEGs (Table 2).
Furthermore, GA repeat-binding protein (GABP), vita-
min D receptor (VDR), forkhead box P1 (FOXP1), and
FLI1 were most significant at T0, while FLI1, forkhead
box P3 (FOXP3), FOXP1, and NOTCH1 at T1. Ignoring
the overlapping transcriptional factor, targets of GABP
at T0 and NOTCH1 at T1 were significantly enriched in
upregulated DEGs.
Significant DEGs-related miRNAs
The screening of significant DEGs-related miRNAs for
downregulated DEGs was performed by Fisher’s exact
test. As shown in Table 3, predicted targets of miR-141/
200a family were obviously enriched in downregulated
DEGs both at T0 and T1.
Construction of PPI network
We mapped DEGs to the STRING database and screened
significant interactions with score larger than 0.4. By
integrating these relationships, we constructed interaction
networks among interactive proteins at T0 (Figure 1) and
T1 (Figure 2). Several proteins including replication pro-
tein A1 (RPA1), MYC, Janus kinase 2 (JAK2), and cyclin
B1 (CCNB1) were screened from PPI network based on
their highest degree, shown in Table 4.
Discussion
IPC is a universal method to reduce ischemia reperfu-
sion injury in several tissues and organs [31]. In this
study, we screened DEGs from biopsies of four control
and four IPC-treated patients who were subjected to
total knee arthroplasty surgery in order to gain insight
into the molecular mechanism of IPC in protection
against ischemia reperfusion injury. A number of DEGs
Table 1 Results of KEGG pathway enrichment analysis of
up- and downregulated genes both at the onset of surgery
(T = 0) and 1 h into the surgery (T = 1)
Term P value Genes
T = 0 upregulated DEGs
hsa00970: aminoacyl-tRNA
biosynthesis
3.045E − 02 FARS2, CARS2, DARS2,
SARS2
T = 1 upregulated DEGs
hsa04130: SNARE interactions
in vesicular transport
4.998E − 03 SNAP29, STX5, BNIP1,
VAMP5, GOSR2




3.461E − 02 HLA-DQB1, IL6, TNF,
HLA-DQA1














3.933E − 02 TARS2, FARS2,
MARS2, EARS2
T = 1 downregulated DEGs
hsa04062: chemokine
signaling pathway
1.919E − 02 PLCB4, GNAI1, TIAM1,
CCR3, CCL19, GRK4, JAK2,
CCL16, CXCL10








4.976E − 02 AKR1C2, CYP7A1,
HSD17B3, AKR1C1
Table 2 Enriched targets of transcriptional factors in
upregulated differentially expressed genes both at the
onset of surgery (T = 0) and 1 h into the surgery (T = 1)
Transcriptional factor P value
T = 0
GABP-19822575 3.5453E − 10
VDR-23849224 4.39418E − 10
FOXP1-21924763 5.58129E − 09
FLI1-21571218 6.78555E − 09
FOXP3-21729870 1.16903E − 08
ETS1-20019798 1.39977E − 08
XRN2-22483619 5.46758E − 08
E2F4-21247883 5.49972E − 06





FLI1-21571218 6.78838E − 11
FOXP3-21729870 2.40847E − 10
FOXP1-21924763 5.84899E − 09
NOTCH1-21737748 1.56938E − 06
XRN2-22483619 5.20959E − 06
MITF-21258399 2.10127E − 05
VDR-23849224 2.1157E − 05
TTF2-22483619 3.85815E − 05
ATF3-23680149 4.62329E − 05
GATA1-21571218 7.06282E − 05
RUNX1-21571218 7.27917E − 05
HNF4A-19822575 0.000155321
DCP1A-22483619 0.000221014
Note: The number following gene symbol is the PubMed ID of the article
which provided the Chip-seq data.
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were identified between IPC group and the control at
T0 and T1.
Moreover, KEGG pathway enrichment analysis showed
that upregulated DEGs were significantly enriched in
aminoacyl-tRNA biosynthesis both at T0 and T1,
SNARE interactions in vesicular transport and p53 sig-
nal pathway at T1. As shown in previous studies, the
expression of ARS (aminoacyl-tRNA synthetases) cod-
ing genes and genes involved in metabolism and trans-
port of amino acids were upregulated after ischemia
but decreased after IPC treatment [32]. Previous re-
port showed that p53 was a caspase inhibitor, which
has been known to stimulate the disruption of mito-
chondria and widely used in studies of apoptosis [33].
P53 expression has also been shown to inhibit apoptosis
induced by tumor necrosis factor-α (TNF-α) in the liver
[34,35]. Furthermore, reperfusion-induced hepatic apop-
tosis could be decreased by IPC through lowering TNF-α
levels and modulating the caspase dependent pathway
[36]. Notably, emerging evidences have pointed out that
Golgi-SNARE GS28 (Golgi SNAP receptor complex mem-
ber 1) forms a complex with p53, and thus affect the sta-
bility and activity of p53 [37]. In addition, GS28 may
enhance cells to DNA-damage-induced apoptosis through
inhibiting the ubiquitination and degradation of p53
[37]. Taken together, IPC might render protection
against reperfusion-induced injury at cellular, organ,
and systemic level partly through aminoacyl-tRNA
biosynthesis, SNARE interactions in vesicular trans-
port and p53 signaling pathways.
To identify transcriptional factor upon Chip-seq gene
profile, we performed ChEA analysis in upregulated
DEGs both at T0 and T1. Results suggested that
NOTCH1 remarkably regulated overexpressed DEGs at
T1 but not at T0. Recent studies have shown that
NOTCH1 assumed a fundamental role in the mecha-
nisms of cerebral ischemia injury [38] through eliciting
protective effects against ischemia injury by decreasing
neuronal apoptosis in mice [39]. IPC-induced NOTCH1
signaling could activate the endogenous neuroprotective
components and decrease the ischemic-reperfusion in-
jury at the early phase after stroke [40]. In addition,
NOTCH1 signaling protected against ischemia-reperfusion
injury partly though PTEN/Akt-mediated anti-nitrative and
anti-oxidative effects [41]. Remarkable miR-141/200a was
member of miR-200 family which was originally associated
with the inhibition of cancer invasion [42] or olfactory
neurogenesis [43]. Lee's group indicated that miR-141/200a
were upregulated early after IPC and they were neuropro-
tective mainly by improving neural cell survival via proly1
hydroxylase 2 (PHD2) silencing and subsequent HIF-1α
(hypoxia-inducible factors-1α) stabilization [44,45]. To sum
Table 3 Enriched potential regulatory microRNAs for
targeting downregulated differentially expressed genes
both at the onset of surgery (T = 0) and 1 h into the
surgery (T = 1)
miR-141/200a targets P value
T = 0
ASTN1, ATP8A1, CHKA, ENAH, GLS, LRRTM2,
PDCD4, PEG3, RGAG1, SCN9A, SNAP91, STRN, STX2,
THRB, TIAM1, TRHDE, WWTR1
0.0071
T = 1
AMPD2, APOLD1, CDC25B, ENAH, FAT3, FBXL2, GPC6,
GPM6B, KALRN, LENG8, MAP4K4, MARK1, MYH10, PEG3,
PLCB4, PTPRD, RBM47, SOX11, THRB, TIAM1, TTLL7, VASH2,
VCAN, VGLL3, WWTR1
0.0076
Figure 1 Protein-protein interaction network for significant differentially expressed genes at T0 (a-b). The network includes two small nets a and
b. Orange circle means upregulated DEG, and blue circle means downregulated DEG. The line indicates one pair interaction between different proteins.
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up, transcriptional factor NOTCH1 and miR-141/200a
might regulate effects of IPC.
To well understand functions of apparent DEGs, we
mapped them to STRING software and obtained PPI
networks at T0 and T1. It is well known that DNA dam-
age and DNA response related proteins were revealed to
play crucial role during ischemia reperfusion injury in
brain and heart. In network at T1, the dual-specificity
tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2),
interacted with RPA1, regulated p53 to induce apoptosis
in response to DNA damage [46]. As a result, we sug-
gested that RPA1 which had the highest degree might play
a role in IPC protection via interacting with DYRK2.
Meanwhile, JAK2 known as a member of Janus kinase
signal transducers and activators of transcription (JAK-
STAT) pathway which protected against ischemia-
reperfusion injury by decreased number of apoptotic
cardiomyocytes, improved functional recovery, and re-
duced infarct size in the early phase of IPC [47]. When
isolated working rat hearts were subjected to ischemia,
tyrosine phosphorylation of JAK2 and STAT3 immedi-
ately increased after IPC stimulus as well as 2 h after
reperfusion [48]. Specially, ischemia-reperfusion could
activate JAK2 and recruit STAT3, resulting in transcrip-
tional upregulation of inducible cyclooxygenase-2 (COX-2)
and nitric oxide synthase (iNOS), which then mediated the
infarct-sparing effects of the late phase of preconditioning
[49]. However, in our research, JAK2 has been shown to be
downregulated in the PPI network which was inconsistent
with previous demonstration. Thus, JAK2 might also par-
ticipate in other pathway to regulate IPC effect when tissue
Figure 2 Protein-protein interaction network for differentially expressed genes at T1 (a-b). The network includes two small nets a and b.
Orange circle means upregulated DEG, and blue circle means downregulated DEG. The line indicates one pair interaction between different proteins.
Table 4 Degree of differentially expressed genes in
protein-protein interaction network both at the onset of
surgery (T = 0) and 1 h into the surgery (T = 1)
Gene Regulated Degree
RPA1 (T = 1) Up 8
MYC (T = 1) Up 7
JAK2 (T = 1) Down 7
CCNB1 (T = 1) Up 6
JUN1 (T = 1) Up 5
TP63 (T = 1) Up 5
CHAF1A (T = 1) Up 4
FOXM1 (T = 1) Up 4
PRPF4 (T = 1) Up 4
RUVBL2 (T = 0) Up 4
FBXO25 (T = 0) Up 4
STX8 (T = 1) Up 4
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was subjected to ischemia-reperfusion. Further studies
will be necessary to elucidate the mechanisms for JAK2 sig-
naling in IPC treatment. In our study, MYC, CCNB1, and
JUN1 with higher degree in PPI network were newly re-
ported associated with IPC protection.
Conclusion
Our study shed new light on the mechanism of IPC effect
and treatment to diseases due to ischemia reperfusion.
Based on the screened significant DEGs, p53 signaling
pathway, transcriptional factor NOTCH1, and miR141/
200a might regulate IPC protective effect to ischemia re-
perfusion injury. Importantly, significant DEGs RPA1 and
JAK2 in PPI network might participate in the protection
of IPC. Although these evidences were obtained, further
research will be indispensable to explore the mechanisms
of previous mentioned genes. On the other hand, experi-
mental verifications in further research were needed to
support our results.
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